547 related articles for article (PubMed ID: 16564720)
1. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.
Wittek R
Int J Infect Dis; 2006 May; 10(3):193-201. PubMed ID: 16564720
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
3. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review.
Hopkins RJ; Lane JM
Clin Infect Dis; 2004 Sep; 39(6):819-26. PubMed ID: 15472814
[TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers.
Hopkins RJ; Kramer WG; Blackwelder WC; Ashtekar M; Hague L; Winker-La Roche SD; Berezuk G; Smith D; Leese PT
Clin Infect Dis; 2004 Sep; 39(6):759-66. PubMed ID: 15472804
[TBL] [Abstract][Full Text] [Related]
6. Smallpox vaccination reactions, prophylaxis, and therapy of complications.
Goldstein JA; Neff JM; Lane JM; Koplan JP
Pediatrics; 1975 Mar; 55(3):342-7. PubMed ID: 238178
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?
Napolitano PG; Ryan MA; Grabenstein JD
Am J Obstet Gynecol; 2004 Dec; 191(6):1863-7. PubMed ID: 15592266
[TBL] [Abstract][Full Text] [Related]
8. Smallpox vaccine: contraindications, administration, and adverse reactions.
Maurer DM; Harrington B; Lane JM
Am Fam Physician; 2003 Sep; 68(5):889-96. PubMed ID: 13678138
[TBL] [Abstract][Full Text] [Related]
9. Transmission of vaccinia virus and rationale for measures for prevention.
Lane JM; Fulginiti VA
Clin Infect Dis; 2003 Jul; 37(2):281-4. PubMed ID: 12856220
[TBL] [Abstract][Full Text] [Related]
10. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
[TBL] [Abstract][Full Text] [Related]
11. Women with smallpox vaccine exposure during pregnancy reported to the National Smallpox Vaccine in Pregnancy Registry--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 May; 52(17):386-8. PubMed ID: 12765202
[TBL] [Abstract][Full Text] [Related]
12. [Confronting bioterrorism: Epidemiologic, clinical, and preventive aspects of smallpox].
Franco-Paredes C; del Río C; Nava-Frías M; Rangel-Frausto S; Téllez I; Santos-Preciado JI
Salud Publica Mex; 2003; 45(4):298-309. PubMed ID: 12974047
[TBL] [Abstract][Full Text] [Related]
13. Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Feb; 52(5):88-9, 99. PubMed ID: 12588007
[TBL] [Abstract][Full Text] [Related]
14. Progressive vaccinia in a military smallpox vaccinee - United States, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):532-6. PubMed ID: 19478722
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
16. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
[TBL] [Abstract][Full Text] [Related]
17. US Civilian Smallpox Preparedness and Response Program, 2003.
Strikas RA; Neff LJ; Rotz L; Cono J; Knutson D; Henderson J; Orenstein WA
Clin Infect Dis; 2008 Mar; 46 Suppl 3():S157-67. PubMed ID: 18284355
[TBL] [Abstract][Full Text] [Related]
18. Ocular vaccinia following exposure to a smallpox vaccinee.
Hu G; Wang MJ; Miller MJ; Holland GN; Bruckner DA; Civen R; Bornstein LA; Mascola L; Lovett MA; Mondino BJ; Pegues DA
Am J Ophthalmol; 2004 Mar; 137(3):554-6. PubMed ID: 15013881
[TBL] [Abstract][Full Text] [Related]
19. Smallpox vaccination--implications for the occupational health professional.
DesRoches P
AAOHN J; 2003 Jun; 51(6):240-2. PubMed ID: 12846455
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
Goldsmith JC; Eller N; Mikolajczyk M; Manischewitz J; Golding H; Scott DE
Vox Sang; 2004 Feb; 86(2):125-9. PubMed ID: 15023182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
